Chennai Petroleum, MRPL, MCX, Avenue Supermarts, Titan, Polycab Are Buzzing On Dealer Desk
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Chennai Petroleum, MRPL, MCX, Avenue Supermarts, Titan and Polycab.

NDTV Profit India has been tracking the action in the top dealing rooms of India’s financial capital, and this edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Chennai Petroleum, MRPL, MCX, Avenue Supermarts, Titan and Polycab.
Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.
NDTV Profit picked up the following cues from the dealing room chatter during Monday's trade:
Chennai Petroleum and MRPL
Dealers indicate that smart investors are shifting funds from oil marketing companies to pure-play oil refiners, as higher refining margins will benefit pure-play refiners more than OMCs. The net benefit is lower for OMCs owing to their exposure to the marketing business.
MCX
There are buy flows on the institutional desk as dealers indicate that MCX, as an exchange, has witnessed strong volumes for the June quarter.
Avenue Supermarts and Titan
Large high-net-worth individuals have been seen buying shares of both these stocks on expectations of good Q1 FY26 updates.
Polycab
Foreign institutional investors accumulate shares of Polycab. Dealers indicate that management commentary suggests strong Q1 earnings, and that is one of the reasons behind this buying action.
Disclaimer: The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.